Differential role of Sloan-Kettering Institute (Ski) protein in nodal and transforming growth factor-beta (TGF-β)-induced smad signaling in prostate cancer cells

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2054-2064

  Vo, BaoHan T ^a   Cody, Bianca ^a   Cao, Yang ^a   Khan, Shafiq A ^a  

^a CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN NODAL; SLOAN KETTERING INSTITUTE PROTEIN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN LNCAP; CELL STRAIN PC3; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR PROMOTION;

BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MALE; NODAL PROTEIN; PHOSPHORYLATION; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84868615823     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs252     Document Type: Article

References (47)

1. Chang, H. et al. (2002) Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev., 23, 787-823.
2. Massagué, J. et al. (2000) Controlling TGF-beta signaling. Genes Dev., 14, 627-644.
3. Zimmerman, C.M. et al. (2000) Transforming growth factor beta signaling mediators and modulators. Gene, 249, 17-30.
4. Miyazawa, K. et al. (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells, 7, 1191-1204.
5. Siegel, P.M. et al. (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer, 3, 807-821.
6. Vallier, L. et al. (2004) Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev. Biol., 275, 403-421.
7. Schier, A.F. et al. (2000) Nodal signalling in vertebrate development. Nature, 403, 385-389.
8. Yeo, C. et al. (2001) Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol. Cell, 7, 949-957.
9. Vo, B.T. et al. (2011) Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration. Prostate, 71, 1084-1096.
10. Lawrence, M.G. et al. (2011) Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate, 71, 1198-1209.
11. Luo, K. et al. (1999) The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev., 13, 2196-2206.
12. Li, Y. et al. (1986) Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J. Virol., 57, 1065-1072.
13. Nomura, N. et al. (1989) Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res., 17, 5489-5500.
14. Fumagalli, S. et al. (1993) Expression of the c-ski proto-oncogene in human melanoma cell lines. Melanoma Res., 3, 23-27.
15. Reed, J.A. et al. (2005) SKI pathways inducing progression of human melanoma. Cancer Metastasis Rev., 24, 265-272.
16. Zhang, F. et al. (2003) Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res., 63, 5005-5010.
17. Imoto, I. et al. (2001) SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem. Biophys. Res. Commun., 286, 559-565.
18. Sun, Y. et al. (1999) Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol. Cell, 4, 499-509.
19. Nomura, T. et al. (1999) Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev., 13, 412-423.
20. Tokitou, F. et al. (1999) Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion. J. Biol. Chem., 274, 4485-4488.
21. Kokura, K. et al. (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. J. Biol. Chem., 276, 34115-34121.
22. Zhong, M. et al. (2010) Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway. Mol. Cancer Res., 8, 1164-1172.
23. Millena, A.C. et al. (2004) Autocrine regulation of steroidogenic function of Leydig cells by transforming growth factor-alpha. Mol. Cell. Endocrinol., 224, 29-39.
24. Vo, B.T. et al. Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration. Prostate, 71, 1084-1096.
25. Miyazawa, K. et al. (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells, 7, 1191-1204.
26. Jinnin, M. et al. (2006) Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol. Pharmacol., 69, 597-607.
27. Luo, K. (2004) Ski and SnoN: negative regulators of TGF-beta signaling. Curr. Opin. Genet. Dev., 14, 65-70.
28. Sun, Y. et al. (1999) SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc. Natl. Acad. Sci. U.S.A., 96, 12442-12447.
29. Xu, W. et al. (2000) Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc. Natl. Acad. Sci. U.S.A., 97, 5924-5929.
30. Akiyoshi, S. et al. (1999) c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J. Biol. Chem., 274, 35269-35277.
31. Deheuninck, J. et al. (2009) Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res., 19, 47-57.
32. Robson, C.N. et al. (1999) Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. J. Endocrinol., 160, 257-266.
33. Bhowmick, N.A. et al. (2005) Tumor-stroma interactions. Curr. Opin. Genet. Dev., 15, 97-101.
34. Sharif-Afshar, A.R. et al. (2005) Stromal hyperplasia in male bladders upon loss of transforming growth factor-beta signaling in fibroblasts. J. Urol., 174(4 Pt 2), 1704-7; discussion 1707.
35. Pu, H.et al. (2009) Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Cancer Res., 69, 7366-7374.
36. Yang, F. et al. (2008) Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Oncogene, 27, 450-459.
37. Yang, J. et al. (2009) Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells. Cancer Res., 69, 2185-2190.
38. Javelaud, D. et al. (2011) Efficient TGF-beta/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. Mol. Cancer, 10, 2.
39. Theohari, I. et al. (2012) Differential effect of the expression of TGF-beta pathway inhibitors, Smad-7 and Ski, on invasive breast carcinomas: relation to biologic behavior. APMIS, 120, 92-100.
40. Villanacci, V. et al. (2008) Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus. Hum. Pathol., 39, 403-409.
41. Bravou, V. et al. (2009) TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis. Cell. Oncol., 31, 41-51.
42. Takahata, M. et al. (2009) SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells. J. Biol. Chem., 284, 3334-3344.
43. Heider, T.R. et al. (2007) Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer. Ann. Surg., 246, 61-68.
44. Berk, M. et al. (1997) Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development. Genes Dev., 11, 2029-2039.
45. Le Scolan, E. et al. (2008) Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res., 68, 3277-3285.
46. Nagano, Y. et al. (2007) Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling. J. Biol. Chem., 282, 20492-20501.
47. Zhu, Q. et al. (2007) Dual role of SnoN in mammalian tumorigenesis. Mol. Cell. Biol., 27, 324-339.